Abstract:Abstract Background Patients with native or post-surgical right ventricular outflow tract (RVOT) dysfunction often require several re-interventions. Percutaneous pulmonary valve implantation (PPVI) has recently been proposed as an attractive alternative to surgery, but there is still lack of data on long-term results. Aim To determine the long-term outcome after PPVI and to investigate whether clinical benefit and cardiac performance improvement is achieved after the procedure. Methods and results Seventy-eight patients (mean age 31.75±11.7) undergoing PPVI between April 2007 and July 2017 at Royal Brompton Hospital were retrospectively included in the study. The median follow-up was 6.1 years (2.1–11.2). Overall survival was 90.8%±4.1 at 6 years and 85%±5.9 at 11 years with freedom from valve failure (defined as either severe stenosis or regurgitation) of 87.6%±5 at 6 years of follow-up. Annual reintervention rate was 3.2% (95% CI 1.6–5.5). Infective endocarditis was a major concern with annual incidence rate of 1.6% (95% CI 0.5–3.4) and 50% of adverse outcome. Male sex (HR 3.2, 95% CI 1.3–7.9, p=0.013), age at procedure>50 years (HR 4.7, 95% CI 1.5–15.1, p=0.01) and residual mean gradient>25 mmHg at immediate postprocedural echo (HR 4.6, 95% CI 1.6–13.5%, p=0.006) were independently associated to the composite endpoint (including death, re-intervention, valve failure and arrhythmia). At latest follow-up, significant NYHA class (Pre Vs 6.1yrs Post p<0.0001) and cardiopulmonary test results improvement (peakVO2 p=0.01) and arrhythmic burden reduction (p=0.002) were found. Both cardiovascular magnetic resonance (CMR) and serial echocardiograms showed biventricular reverse remodeling (Pre Vs 1.3yrs Post CMR: RVEDVi p=0.0002, RVESVi p=0.0012, LVEDVi p=0.028). Furthermore, speckle tracking assessments demonstrated significant improvement of RV free wall GLS (Pre Vs 6.4yrs Post p=0.03) and LV GLS (p=0.01) at long-term. Moreover, concomitant improvement of RV relaxation properties was suggested by echo evidence of right atrial (RA) reverse remodeling (Pre Vs 6.4yrs Post RA area p=0.0001), increased RA strain (p=0.0005) and reduction of the patients with restrictive RV physiology (p<0.0001). Conclusion PPVI is a reliable alternative to surgery with long-lasting favourable clinical effects associated with significant and persistent structural biventricular reverse remodeling and global systolic and diastolic functional improvement. Valve failure and infective endocarditis remain major complications during follow-up. Older and male patients and those with residual transvalvular gradients immediately post procedure are at higher risk of adverse clinical events, thus suggesting that re-intervention should be anticipated and that complete relief of RVOT obstruction should be pursued. Kaplan-Meier curves for survival free from VF Funding Acknowledgement Type of funding source: None

[Direct Vision Mitral Valve Reconstruction: a Long-Term Follow-Up of 46 Cases].

[Long-Term Results of Mitral-Aortic Valve Replacement in 1,154 Patients with Rheumatic Valvular Disease].

LONG-TERM FOLLOW UP OF 351 CASES OF HEART VALVE REPLACEMENT WITH BIOPROSTHESES

Mitral valve reconstruction in the aged(46 cases report attached)

Long-term Outcomes Following Valve-Sparing Root Replacement with Concomitant Mitral Repair

Midterm Outcome of Valve Repair for Rheumatic Mitral Stenosis: 6-year Experience in a Single Mid-Volume Cardiac Center

Outcomes of Mitral Valve Repair for Degenerative Mitral Disease: A Single-Centre 10-Year Experience.

Early and long-term outcomes of mitral valve repair in degenerative mitral regurgitation

Long-term follow-up of repair-like replacement of mitral valve using autologous pericardium

Late results of mitral valve repair for mitral regurgitation due to degenerative disease

[Long-Term Results of Prosthetic Mitral Valve Replacement with Home-Made Tilting Disc Valve: a Report of 125 Cases].

Mid-term results of mitral valve replacement and repair: current clinical experience, technical aspects, and risk factor analysis

Clinical Study of the Efficacy of Different Types of Surgery in Elderly Patients with Mitral Valve Disease

Early and late Results after Surgical Mitral Valve Repair: A High-Volume Center Experience

Results of 131 combined mitral and aortic valve replacement for rheumatic valvlar disease

Long-term Follow-Up after Percutaneous Pulmonary Valve Implantation: Sustained Clinical Benefit with Evidence of Persistent Biventricular Reverse Remodeling and Improved Global Performance

Transcatheter mitral valve-in-valve implantation: a 10-year single center experience

Minimally invasive direct access mitral valve surgery

High-risk mitral valve replacement in severe pulmonary hypertension--30 years experience

Outcome after mitral valve operations with depressed left ventricular function

P1755 Clinical and echocardiographic outcomes of mitral valve repair surgery